Guardion Health Sciences (GHSI) Stock Price, News & Analysis

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares.
View GHSI analyst ratings or view top-rated stocks.

Guardion Health Sciences' stock was trading at $5.34 on January 1st, 2024. Since then, GHSI stock has increased by 50.6% and is now trading at $8.04.
View the best growth stocks for 2024 here.

Guardion Health Sciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 139,800 shares, an increase of 14.2% from the March 15th total of 122,400 shares. Based on an average daily trading volume, of 208,600 shares, the short-interest ratio is currently 0.7 days. Currently, 13.7% of the company's stock are sold short.
View Guardion Health Sciences' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our GHSI earnings forecast.

Guardion Health Sciences, Inc. (NASDAQ:GHSI) announced its quarterly earnings results on Monday, August, 12th. The company reported ($42.00) earnings per share for the quarter. The business earned $0.26 million during the quarter. Guardion Health Sciences had a net margin of 0.51% and a trailing twelve-month return on equity of 2.01%.

Guardion Health Sciences's stock reverse split before market open on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).

Guardion Health Sciences (GHSI) raised $6 million in an initial public offering on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.